<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>91(7-S)</volume><submitter>Luzzi S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Adoptive immunotherapies are among the pillars of ongoing biological breakthroughs in neuro-oncology, as their potential applications are tremendously wide. The present literature review comprehensively classified adoptive immunotherapies in neuro-oncology, provides an update, and overviews the main translational challenges of this approach.&lt;h4>Methods&lt;/h4>The PubMed/MEDLINE platform, Medical Subject Heading (MeSH) database, and ClinicalTrials.gov website were the sources. The MeSH terms "Immunotherapy, Adoptive," "Cell- and Tissue-Based Therapy," "Tissue Engineering," and "Cell Engineering" were combined with "Central Nervous System," and "Brain." "Brain tumors" and "adoptive immunotherapy" were used for a further unrestricted search. Only articles published in the last</pubmed_abstract><journal>Acta bio-medica : Atenei Parmensis</journal><pagination>18-31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7975830</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.</pubmed_title><pmcid>PMC7975830</pmcid><pubmed_authors>Magistrali M</pubmed_authors><pubmed_authors>Luzzi S</pubmed_authors><pubmed_authors>Mosconi M</pubmed_authors><pubmed_authors>Savasta S</pubmed_authors><pubmed_authors>Giotta Lucifero A</pubmed_authors><pubmed_authors>Foiadelli T</pubmed_authors><pubmed_authors>Brambilla I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.</name><description>&lt;h4>Background&lt;/h4>Adoptive immunotherapies are among the pillars of ongoing biological breakthroughs in neuro-oncology, as their potential applications are tremendously wide. The present literature review comprehensively classified adoptive immunotherapies in neuro-oncology, provides an update, and overviews the main translational challenges of this approach.&lt;h4>Methods&lt;/h4>The PubMed/MEDLINE platform, Medical Subject Heading (MeSH) database, and ClinicalTrials.gov website were the sources. The MeSH terms "Immunotherapy, Adoptive," "Cell- and Tissue-Based Therapy," "Tissue Engineering," and "Cell Engineering" were combined with "Central Nervous System," and "Brain." "Brain tumors" and "adoptive immunotherapy" were used for a further unrestricted search. Only articles published in the last</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-04T08:27:45.162Z</modification><creation>2025-04-04T08:27:45.162Z</creation></dates><accession>S-EPMC7975830</accession><cross_references><pubmed>32608373</pubmed><doi>10.23750/abm.v91i7-S.9952</doi></cross_references></HashMap>